Molecular modeling of prion transmission to humans

Area of Science:

• Neuroscience
• Molecular Biology
• Veterinary Medicine

Background:

• Prion diseases, like Creutzfeldt-Jakob disease (CJD) and bovine spongiform encephalopathy (BSE), pose significant public health and animal health concerns.
• Understanding interspecies prion transmission barriers is crucial for assessing zoonotic potential and developing diagnostic tools.
• Protein misfolding cyclic amplification (PMCA) is an in vitro technique that mimics prion replication.

Purpose of the Study:

• To evaluate the reliability of PMCA in modeling prion transmission barriers, including interspecies and genetic factors.
• To compare PMCA amplification results with in vivo prion disease transmission data (attack rates).
• To assess the utility of PMCA for studying the zoonotic potential of novel prion strains.

Main Methods:

• Utilized various prion strains, including variant CJD and atypical BSE agents.
• Employed transgenic mice expressing human or bovine prion protein as substrates.
• Tested 19 different prion strain/mouse model (seed/substrate) combinations.
• Compared in vitro PMCA amplification results with in vivo prion disease attack rates in inoculated mice.

Main Results:

• Significant PMCA amplification was observed exclusively when the prion strain's substrate was susceptible to that specific strain.
• PMCA results correlated with in vivo transmission data, indicating its predictive capability for prion barriers.
• The study successfully modeled genetic barriers to prion transmission using different mouse prion protein genotypes.

Conclusions:

• PMCA serves as a valuable tool for investigating genetic barriers that govern prion disease transmission.
• The findings support the use of PMCA to assess the zoonotic potential of emerging prion strains.
• PMCA's ability to predict transmission success highlights its utility in prion disease research and surveillance.